3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
3
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
Breast
1
Conditions
Sarcoma
2
Osteosarcoma
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms, Unknown Primary
1
Interventions
Temozolomide
48
Bevacizumab
29
Carmustine
17
Erlotinib Hydrochloride
16
Radiotherapy
14
Irinotecan
14
Surgical Procedures, Operative
10
Sirolimus
10
Imatinib Mesylate
10
Carboplatin
10
Sorafenib
9
O(6)-benzylguanine
9
Filgrastim
9
Etoposide
8
temsirolimus
7
sargramostim
7
Radiosurgery
7
Radiation
7
Procarbazine
7
Magnetic Resonance Spectroscopy
7
Cyclophosphamide
7
aldesleukin
6
Topotecan
6
Thalidomide
6
Vorinostat
5
Thiotepa
5
Peripheral Blood Stem Cell Transplantation
5
Hydroxyurea
5
Gefitinib
5
Everolimus
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
Patient Reported Outcome Measures
×
Sarcoma
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled